Future Directions in Standards for RWD Quality and Audit Frameworks The evolving landscape of real-world data (RWD) is significantly impacting the pharmaceutical and medical device sectors. Regulatory, biostatistics, and health economics professionals must comprehend the intricacies of RWD quality, integrity, and bias management to navigate this complex terrain effectively. This tutorial offers a comprehensive overview of future directions in standards for RWD quality and audit frameworks, aiming to equip professionals in the pharma and medtech industries with essential insights and actionable guidance. Understanding Real-World Data (RWD) and Its Importance Real-world data refers to data relating to patient health status and…

KPIs and Dashboards to Monitor Ongoing RWD Quality Performance In recent years, the significance of real-world data (RWD) has escalated in the pharmaceutical and medical devices sectors, particularly with the increasing focus on real-world evidence (RWE) in regulatory submissions. Consequently, ensuring the quality, integrity, and bias management of RWD is paramount for making sound regulatory decisions. This guide provides a comprehensive overview of the key performance indicators (KPIs) and dashboards needed to effectively monitor the ongoing performance of RWD quality. Understanding the Importance of RWD Quality RWD encompasses a variety of data types, including electronic health records (EHRs), medical claims…

Training RWE Teams on Bias Concepts and Causal Inference Fundamentals Introduction to Real World Data (RWD) Quality and Integrity As the utilization of Real World Data (RWD) becomes indispensable in pharmaceutical and medtech sectors, understanding its quality and integrity is paramount. RWD refers to the data relating to patient health, healthcare delivery, and outcomes derived from various sources outside traditional clinical trials. The effectiveness of RWD hinges on its quality, derived primarily from accuracy, completeness, and fitness for purpose. A significant aspect of maintaining high standards in RWD quality integrity bias management involves addressing potential biases in data collection and…

Automation and AI Tools for Anomaly Detection in Large RWD Assets As regulatory, biostatistics, Health Economics and Outcomes Research (HEOR), and Real-World Evidence (RWE) professionals engage with large datasets, it is imperative to understand and ensure the quality, integrity, and bias management of Real-World Data (RWD). In this tutorial, we will explore the step-by-step application of automation and Artificial Intelligence (AI) tools for anomaly detection in large RWD assets. We emphasize the need for rigorous data governance to address issues like selection bias, misclassification, and data provenance, ultimately enhancing the RWD fitness for purpose within the regulatory framework. Step 1:…

Documentation Practices that Demonstrate RWD Quality to Regulators In the ever-evolving landscape of healthcare, the significance of Real-World Data (RWD) has grown dramatically, especially in supporting regulatory decision-making. The U.S. Food and Drug Administration (FDA) emphasizes the imperative for high-quality RWD to ensure that the evidence generated is reliable, valid, and applicable. This guide provides a comprehensive overview of the documentation practices that can demonstrate the quality, integrity, and management of bias in RWD, essential for regulatory professionals, biostatisticians, and others engaged in health economics and outcomes research (HEOR). Understanding RWD and Its Regulatory Importance Real-world data can be defined…